She previously served as Chief Executive Officer at Harpoon Therapeutics until the company’s acquisition by Merck in early 2024 ... scientist at the University Hospital of Dusseldorf in Germany and ...
1d
Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...
The focus is on the application of Artificial Intelligence for innovations aimed at making semiconductor processes more sustainable DARMSTADT, Germany, November 07, 2024--(BUSINESS WIRE)--Merck ...
German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world’s largest semiconductor designers and ...
The focus is on the application of Artificial Intelligence for innovations aimed at making semiconductor processes more sustainable DARMSTADT, Germany, November 07, 2024--(BUSINESS WIRE)--Merck KGaA, ...
Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.
Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...
The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback